White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease
- PMID: 32798911
- PMCID: PMC7453140
- DOI: 10.1016/j.nicl.2020.102367
White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease
Abstract
Neuropsychiatric symptoms (NPS), such as apathy, irritability and depression, are frequently encountered in patients with Alzheimer's disease (AD). Focal grey matter atrophy has been linked to NPS development. Cerebrovascular disease is common among AD patients and can be detected on MRI as white matter hyperintensities (WMH). In this longitudinal study, the relative contribution of WMH burden and GM atrophy to NPS was evaluated in a cohort of mild cognitive impairment (MCI), AD and normal controls. This study included 121 AD, 315 MCI and 225 normal control subjects from the Alzheimer's Disease Neuroimaging Initiative. NPS were assessed using the Neuropsychiatric Inventory and grouped into hyperactivity, psychosis, affective and apathy subsyndromes. WMH were measured using an automatic segmentation technique and mean deformation-based morphometry (DBM) was used to measure atrophy of grey matter regions. Linear mixed-effects models found focal grey matter atrophy and WMH volume both contributed significantly to NPS subsyndromes in MCI and AD subjects, however, WMH burden played a greater role. This study could provide a better understanding of the pathophysiology of NPS in AD and support the monitoring and control of vascular risk factors.
Keywords: Alzheimer’s disease; Cerebrovascular disease; Mild cognitive impairment; Neuropsychiatric symptoms; White matter hyperintensity.
Copyright © 2020. Published by Elsevier Inc.
Figures




References
-
- Lyketsos C.G., Lopez O., Jones B., Fitzpatrick A.L., Breitner J., DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA. 2002;288:1475–1483. - PubMed
-
- Kaufer D.I., Cummings J.L., Christine D. Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale. J. Am. Geriatr. Soc. 1998;46:210–215. - PubMed
-
- Ryu S.H., Katona C., Rive B., Livingston G. Persistence of and changes in neuropsychiatric symptoms in Alzheimer disease over 6 months: the LASER-AD study. Am. J. Geriatr. Psychiatry. 2005;13:976–983. - PubMed
-
- Palmer K., Di Iulio F., Varsi A.E. Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy. J. Alzheimers Dis. 2010;20:175–183. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical